+39 02 610346.1 - info@newron.com

Latest press releases

  • 1Feb
    Newron Completes Patient Enrollment in Pivotal STARS Study

     

  • 31Jan
    Newron Pharmaceuticals to Present at the 21st Annual BIO CEO & Investor Conference in New York

  • 16Jan
    Zambon together with Valeo Pharma announce the approval of Onstryv® (safinamide) for PD in Canada

  • 30Nov
    Zambon announces approval and ARTG listing of safinamide in Australia for treatment of patients with Parkinson’s disease

     

  • 31Oct
    Newron Pharmaceuticals hosts its 2018 R&D Day in New York City

  • 30Oct
    Investment Plan for Europe: EIB backs Italian CNS drug developer Newron Pharmaceuticals with up to EUR 40m

     

View All

Newron share price

Events

  • 7Apr
    H.C. Wainwright Global Life Sciences Conference 2019

    April 7-9, 2019 - Grosvenor House, London, UK

  • 27Feb
    2019 Leerink Partners Gloal Healthcare Conference

    February 27 - March 1, 2019 - Lotte New York Palace Hotel, New York, USA

  • 11Feb
    BIO CEO & Investor Conference 2019

    February 11-12, 2019 - Marriott Marquis, New York, NY, USA

View Event Calendar